Howard Clowes
CIK: 0001806992
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CERENOME, INC.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 1, 2026CNSY
CERENOME, INC.
Exercise(M)Direct921 shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct922 shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
3.7K shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
3.7K shares- - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
297.8K shares- - Feb 18, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
40.1K shares- - Sep 11, 2024PSTV
PLUS THERAPEUTICS, INC.
Purchase(P)Direct5K shares at avg. $1.34$7K - Sep 11, 2024PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
3.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | CNSY CERENOME, INC. | Exercise(M) | 921 | - | $0 | Direct |
| Jul 1, 2026 |  PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 922 | - | $0 | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 3,686 | - | - | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 3,686 | - | - | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 297,794 | - | - | Direct |
| Feb 18, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 40,122 | - | - | Direct |
| Sep 11, 2024 | PSTV PLUS THERAPEUTICS, INC. | Purchase(P) | 5,000 | $1.34 | $6,681 | Direct |
| Sep 11, 2024 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 3,650 | - | - | Direct |
1-8 of 8 transactions
About Clowes Howard
Clowes Howard (SEC CIK 0001806992) files insider reports with the SEC as Director of CERENOME, INC. (CNSY).
Signal8 holds 7 ownership filings by Clowes Howard, all Form 4s, filed between Sep 12, 2024 and Oct 1, 2026. Those filings report 8 transactions, from Sep 11, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Clowes Howard's filings is in HOUSTON, TX.
Recent filings by Clowes Howard
- Oct 1, 2026: Option exercise of CNSY shares (Form 4, code M).
- Jul 1, 2026: Option exercise of PSTV shares (Form 4, code M).
- May 14, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
- Aug 13, 2025: Grant or award of PSTV derivative securities (Form 4, code A).
- Feb 18, 2025: Grant or award of PSTV derivative securities (Form 4, code A).
Other insiders filing for CERENOME, INC. (CNSY)
- van Es-Johansson An, Director
- Hawkins Richard J, Director
- Sims Andrew John Hugh MacIntyre, Chief Financial Officer
- HEDRICK MARC H, Chief Executive Officer
- ANDREWS RONALD ASBURY, Director
- Guse Kyle, Director